BPI-Theater-header

These presentations, interviews, and panel discussions took place at the BPI Theater at BIO 2019. Centering the presentations around two key themes — emerging therapies and technologies — enabled the theater speakers and attendees to engage complex, interconnected topics that are of interest to BPI readers. Speakers highlighted how their companies are responding to both challenges and opportunities relating to manufacturing technique and capacity, particularly where it concerns expressing and mass-producing novel proteins. Presenters also reflected on how far the biopharmaceuticals industry has come and where it can go in the age of individualized cell and gene therapies.

View the full presentations by following the links below.

Insider-Interview-Metantzoglu

BioProcess Insider BPI Theater @ BIO 2019 Interviews — Tuesday
Featuring Konstantin Matentzoglu, Chief Executive Officer of the CELONIC Group

2019_BIO_Dailies_GE

BioProcess Insider BPI Theater @ BIO 2019 Interviews — Tuesday
Featuring Catarina Flyborg, General Manager of Cell and Gene Therapy Business at GE Healthcare

Insider-Interview-Phelan

BioProcess Insider BPI Theater @ BIO 2019 Interviews — Tuesday
Featuring Maurice Phelan, Site Head of Cambridge US at Sartorius Stedim Biotech

Dailies_Pfenex

BioProcess Insider BPI Theater @ BIO 2019 Interviews — Wednesday
Featuring Patrick Lucy, Chief Business Officer at Pfenex

2019_Dailies_Lonza

BioProcess Insider BPI Theater @ BIO 2019 Interviews — Wednesday
Featuring Stéphane Varray, Associate Director of Commercial Development for Midscale at Lonza Pharma and Biotech

BioProcess Insider BPI Theater @ BIO 2019 Interviews — Wednesday
Featuring Tom Cartwright, Partner at Morgan Lewis